Results for tag: "Deferiprone"

Deferiprone is a hematological drug used to treat iron overload in patients with thalassemia, a genetic blood disorder. It is an oral chelator, meaning it binds to iron in the body and helps to remove it from the bloodstream. Deferiprone works by reducing the amount of iron in the body, which can help to reduce the symptoms of thalassemia. It is also used to treat other conditions such as sickle cell anemia, myelodysplastic syndrome, and aplastic anemia. Deferiprone is available in both generic and brand-name forms. It is typically taken three times a day, with or without food. Common side effects include nausea, vomiting, and diarrhea. More serious side effects may include liver damage, anemia, and low white blood cell count. The deferiprone market is highly competitive, with several companies offering their own versions of the drug. Some of the major players in the market include Novartis, Sanofi, and Teva Pharmaceuticals. Other companies include Actavis, Apotex, and Mylan. Show Less Read more